Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Oligometastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
- Status
- RECRUITING
- Phase
- PHASE2
Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)
- Status
- RECRUITING
- Phase
- N/A
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
- Status
- RECRUITING
- Phase
- NA
Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
Radiotherapy for Oligometastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- NA